Acute Kidney Injury News

A simple test can help predict which patients with acute kidney injury will likely develop serious kidney problems and die in the hospital, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN). Using this test could help clinicians safeguard patients’ health.

Ortho-Clinical Diagnostics Inc. has started marketing to hospitals the NephroCheckTest System, designed to help health care providers identify patients at risk of developing moderate or severe acute kidney injury within 12 hours of patient assessment. The FDA approved the test, manufactured by Astute Medical, in September.

Acute kidney injury affects 1 in 5 hospitalized patients worldwide

Clinicians recently accomplished the first known successful delivery of renal replacement therapy with subsequent recovery of kidney function in a patient with Ebola virus disease. Their protocol was presented at the American Society of Nephrology's Kidney Week 2014. It will also appear in an upcoming issue of the Journal of the American Society of Nephrology (JASN) and was released on the JASN website on Nov. 14th.

The U.S. Food and Drug Administration has approved marketing of the NephroCheck test, a laboratory test to help determine if certain critically ill hospitalized patients are at risk of developing moderate to severe acute kidney injury (AKI) in the 12 hours following the administration of the test. The NephroCheck Test System is manufactured by Astute Medical based in San Diego.

Researchers have found a way to reduce kidney injury in patients undergoing a procedure with contrast dye, using quality improvement measures.

Acute kidney injury (AKI) and chronic kidney disease are closely intertwined, with each disease a risk factor for developing the other, according to a comprehensive analysis by scientists at the National Institutes of Health and George Washington University Medical Center in Washington, D.C. The diseases also have similar factors that cause them to get worse, and similar outcomes, the study suggest. Findings were published July 3 in the New England Journal of Medicine.

An intervention that reduces the risk of acute kidney injury may not necessarily improve surgery patients’ long-term kidney function, according to an abstract presented at the American Society of Nephrology's Kidney Week 2013, "Acute Kidney Injury from Off-Pump or On-Pump Coronary Bypass Grafting and Kidney Function One Year Later (Abstract 5812)."

Acute kidney injury may be more deadly than a heart attack, according to a study appearing in an upcoming issue of the Clinical Journal of the American Society of Nephrology (CJASN). The findings suggest that follow-up and surveillance may be critical to protect the health of individuals who develop this form of kidney damage. Acute kidney injury (AKI) is an abrupt decline in kidney function that often arises after major surgeries or severe infections.

Acute kidney injury (AKI) is the most common in-hospital diagnosis seen by U.S. nephrologists, but patients with the condition may not be receiving sufficient follow-up care, according to a new study. The findings of the study, “The Daily Burden of Acute Kidney Injury: A World Kidney Day Survey of U.S. Nephrologists” (Abstract 1444), will be presented at ASN Kidney Week 2013.